EgCF mediates macrophage polarisation by influencing the glycolytic pathway.

Glycolysis HIF-1α macrophage polarisation

Journal

Journal of helminthology
ISSN: 1475-2697
Titre abrégé: J Helminthol
Pays: England
ID NLM: 2985115R

Informations de publication

Date de publication:
21 Dec 2023
Historique:
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: epublish

Résumé

Human cystic echinococcosis (CE) is a zoonotic disorder triggered by the larval stage of

Identifiants

DOI: 10.1017/S0022149X23000548 PMID: 38124668
pubmed: 38124668
doi: 10.1017/S0022149X23000548
pii: S0022149X23000548
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e101

Auteurs

Yeye Feng (Y)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
ORCID: 0000-0002-9224-1041

Junying Xu (J)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Junxia Lu (J)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Jun Hou (J)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Lianghai Wang (L)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Dan Dong (D)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Xian Wang (X)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Xiaofang Wang (X)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Xiangwei Wu (X)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of General Surgery, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.

Xueling Chen (X)

NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Department of Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
ORCID: 0000-0001-5014-8570

Classifications MeSH